BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22432757)

  • 21. Minimum absolute graft weight of 650 g predicts a good outcome in living donor liver transplant despite a graft recipient body weight ratio of less than 0.8.
    Agarwal S; Selvakumar N; Rajasekhar K; Dey R; Verma S; Gupta S
    Clin Transplant; 2019 Oct; 33(10):e13705. PubMed ID: 31498506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
    Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
    Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic evaluation of patients undergoing living-donor liver transplant by APACHE II and MELD scores.
    Zhang ZY; Chen R; Zhou ZQ; Peng CH; Zhou GW
    Exp Clin Transplant; 2015 Feb; 13(1):41-5. PubMed ID: 24779711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Pretransplant Infections on Clinical Outcomes in Live-Donor Liver Transplant Recipients.
    Cinar G; Kalkan İA; Azap A; Kirimker OE; Balci D; Keskin O; Yuraydin C; Ormeci N; Dokmeci A
    Transplant Proc; 2019 Sep; 51(7):2434-2438. PubMed ID: 31474298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Tanemura A; Mizuno S; Kato H; Murata Y; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2016 May; 48(4):1025-31. PubMed ID: 27320548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of HLA compatibility in pediatric living-related liver transplantation.
    Kasahara M; Kiuchi T; Uryuhara K; Uemoto S; Fujimoto Y; Ogura Y; Oike F; Kaihara S; Egawa H; Tanaka K
    Transplantation; 2002 Oct; 74(8):1175-80. PubMed ID: 12438966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
    Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with living related liver transplantation in 63 children.
    Otte JB; Reding R; de Ville de Goyet J; Sokal E; Lerut J; Janssen M; Rosati R; Hayez JY; Libert F; Paul K; Latinne D
    Acta Gastroenterol Belg; 1999; 62(3):355-62. PubMed ID: 10547903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
    Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of critically-ill children after living-donor liver transplant.
    Elgendy H; El Moghazy WM; Nafady-Hego H; Uemoto S
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():100-7. PubMed ID: 25894136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human leukocyte antigen compatibility and lymphocyte cross-matching play no significant role in the current adult-to-adult living donor liver transplantation.
    Badawy A; Kaido T; Yoshizawa A; Yagi S; Fukumitsu K; Okajima H; Uemoto S
    Clin Transplant; 2018 Apr; 32(4):e13234. PubMed ID: 29499077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting graft and patient survival after live donor kidney transplantation in the UK.
    Fuggle SV; Allen JE; Johnson RJ; Collett D; Mason PD; Dudley C; Rudge CJ; Bradley JA; Watson CJ;
    Transplantation; 2010 Mar; 89(6):694-701. PubMed ID: 20308863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octogenarian liver grafts: Is their use for transplant currently justified?
    Jiménez-Romero C; Cambra F; Caso O; Manrique A; Calvo J; Marcacuzco A; Rioja P; Lora D; Justo I
    World J Gastroenterol; 2017 May; 23(17):3099-3110. PubMed ID: 28533667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of Proper Graft Selection in Adult Living-Donor Liver Transplant Recipients with Preoperative Deteriorated Condition.
    Iida T; Masuda K; Matsuyama T; Harada S; Nakamura T; Koshino K; Suzuki T; Nobori S; Ushogome H; Ito T; Sakamoto S; Uryuhara K; Okajima H; Kaihara S; Uemoto S; Yoshimura N
    Ann Transplant; 2017 Sep; 22():541-549. PubMed ID: 28883387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large-for-size liver transplant: a single-center experience.
    Akdur A; Kirnap M; Ozcay F; Sezgin A; Ayvazoglu Soy HE; Karakayali Yarbug F; Yildirim S; Moray G; Arslan G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():108-10. PubMed ID: 25894137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.
    Kollmann D; Sapisochin G; Goldaracena N; Hansen BE; Rajakumar R; Selzner N; Bhat M; McCluskey S; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
    Liver Transpl; 2018 Jun; 24(6):779-789. PubMed ID: 29604237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The liver recipient with acute renal dysfunction: A single institution evaluation of the simultaneous liver-kidney transplant candidate.
    Yadav K; Serrano OK; Peterson KJ; Pruett TL; Kandaswamy R; Bangdiwala A; Ibrahim H; Israni A; Lake J; Chinnakotla S
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29105843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.